Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines

Yi He Ling, Tianhong Li, Ziqiang Yuan, Missak Haigentz, Thomas K. Weber, Roman Perez-Soler

Research output: Contribution to journalArticle

68 Scopus citations

Fingerprint Dive into the research topics of 'Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27<sup>KIP1</sup> up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines'. Together they form a unique fingerprint.

Medicine & Life Sciences